Biogen Idec to Present at the Stifel Nicolaus Healthcare Conference 2012
WESTON, Mass.--(BUSINESS WIRE)--Aug. 29, 2012--
Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at
the Stifel Nicolaus Healthcare Conference 2012 will be webcast live on
Wednesday, September 5, 2012 at 8:00 a.m. ET. To access the live
webcast, please visit Biogen Idec’s Investor Relations section (www.investor.biogenidec.com).
An archived version of the webcast will be available for 14 days
following the presentation.
About Biogen Idec
Through cutting-edge science and medicine,
Biogen Idec discovers, develops and delivers to patients worldwide
innovative therapies for the treatment of neurodegenerative diseases,
hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the
world’s oldest independent biotechnology company. Patients worldwide
benefit from its leading multiple sclerosis therapies, and the company
generates more than $5 billion in annual revenues. For product labeling,
press releases and additional information about the company, please
visit www.biogenidec.com.
Source: Biogen Idec Inc.
Biogen Idec
Karen Jewell, 781-464-2442
Investor Relations
